Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol

BACKGROUND: Many patients with chronic obstructive pulmonary disease (COPD) continue to suffer exacerbations, even when treated with maximum recommended therapy (eg, inhaled combinations of long-acting β(2)-agonist and high dose inhaled corticosteroids, with or without a long-acting anticholinergic...

Descripción completa

Detalles Bibliográficos
Autores principales: Calverley, Peter MA, Martinez, Fernando J, Fabbri, Leonardo M, Goehring, Udo-Michael, Rabe, Klaus F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393336/
https://www.ncbi.nlm.nih.gov/pubmed/22791991
http://dx.doi.org/10.2147/COPD.S31100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393336/
https://www.ncbi.nlm.nih.gov/pubmed/22791991
http://dx.doi.org/10.2147/COPD.S31100

Ejemplares similares